March 6, 2020 / 12:38 PM / a month ago

BRIEF-FDA Grants Neurostar Advanced Therapy System Breakthrough Device Designation To Treat Bipolar Depression

March 6 (Reuters) - Neuronetics Inc:

* FDA GRANTS NEUROSTAR® ADVANCED THERAPY SYSTEM BREAKTHROUGH DEVICE DESIGNATION TO TREAT BIPOLAR DEPRESSION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below